Benexate
From Self-sufficiency
| File:Benexate.png | |
| Systematic (IUPAC) name | |
|---|---|
|
phenylmethyl 2-[4-[(diaminomethylideneamino)methyl]cyclohexanecarbonyl]oxybenzoate | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 78718-52-2 |
| ATC code | none |
| PubChem | CID 2316 |
| ChemSpider | 2226 |
| Chemical data | |
| Formula | C23H27N3O4 |
| Molar mass | 409.47 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Benexate (INN) is a drug used in the treatment of acid-related disorders.
| 45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Drugs acting on the gastrointestinal system and metabolism
- Guanidines
- Gastrointestinal system drug stubs
- 2Fix
